SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-14-414328
Filing Date
2014-11-17
Accepted
2014-11-17 08:33:07
Documents
3
Group Members
ACTAVIS W.C. HOLDING INCDELAWARE MERGER SUB, INC.

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A d821657dsctota.htm SC TO-T/A 32214
2 EX-99.(A)(1)(J) d821657dex99a1j.htm EX-99.(A)(1)(J) 12273
3 GRAPHIC g821657image002.gif GRAPHIC 2892
  Complete submission text file 0001193125-14-414328.txt   50350
Mailing Address 200 SOUTH WACKER DRIVE SUITE 2550 CHICAGO IL 60606
Business Address 200 SOUTH WACKER DRIVE SUITE 2550 CHICAGO IL 60606 312-219-7000
Durata Therapeutics, Inc. (Subject) CIK: 0001544116 (see all company filings)

IRS No.: 871247903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-86923 | Film No.: 141226464
SIC: 2834 Pharmaceutical Preparations

Mailing Address 70 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 2
Business Address 70 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 2 (216) 523-5000
Actavis plc (Filed by) CIK: 0001578845 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: SC TO-T/A
SIC: 2834 Pharmaceutical Preparations